CYTOKINETICS INC Net Income Loss

• CYTOKINETICS INC showed a decrease of -33.2% in Net Income Loss from 2024 to 2025.
• This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2006 to 2025), CYTOKINETICS INC's Net Income Loss has declined by 1,274.3%.
• Historical annual values: Fiscal year 2025: -$784.96 million | Fiscal year 2024: -$589.53 million | Fiscal year 2023: -$526.24 million | Fiscal year 2022: -$388.96 million | Fiscal year 2021: -$215.31 million | Fiscal year 2020: -$127.29 million | Fiscal year 2019: -$121.69 million | Fiscal year 2018: -$106.29 million | Fiscal year 2017: -$127.79 million | Fiscal year 2016: $16.45 million | Fiscal year 2015: -$37.50 million | Fiscal year 2014: -$14.65 million | Fiscal year 2013: -$33.72 million | Fiscal year 2012: -$40.37 million | Fiscal year 2011: -$47.86 million | Fiscal year 2010: -$49.29 million | Fiscal year 2009: $24.54 million | Fiscal year 2008: -$56.37 million | Fiscal year 2007: -$48.89 million | Fiscal year 2006: -$57.12 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026